Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection

Parasitology International

Volumn 57, Issue 4, 2008, Pages 506-508

  Pacheco, Luis G C ^a   Mati, Vítor L T ^a   Castro, Thiago L P ^a   Dorella, Fernanda A ^a   Oliveira, Sérgio C ^a   Miyoshi, Anderson ^a   de Melo, Alan L ^a   Azevedo, Vasco ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

DNA vaccine; Granuloma; Oral vaccination; Salmonella; Schistosoma mansoni; Sm14

Indexed keywords

DNA VACCINE; FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SCHISTOSOMA VACCINE; SM14 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA IMMUNIZATION; DNA TRANSFECTION; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOMATOUS INFLAMMATION; HUMORAL IMMUNITY; LIVER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; WORM INFECTION;

ADMINISTRATION, ORAL; ANIMALS; FATTY ACID TRANSPORT PROTEINS; FEMALE; GRANULOMA; HELMINTH PROTEINS; IMMUNIZATION; LIVER; MICE; PLASMIDS; SALMONELLA TYPHIMURIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES, ATTENUATED; VACCINES, DNA;

MUS; SALMONELLA; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 53049105375     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2008.04.010     Document Type: Article

References (26)

1. Chitsulo L., Loverde P., and Engles D. Schistosomiasis. Nat Rev Microbiol 2 (2004) 12-13
2. Wilson R.A., and Coulson P.S. Schistosome vaccines: a critical appraisal. Mem Inst Oswaldo Cruz 101 1 (2006) 13-20
3. Capron A., Riveau G.J., Bartley P.B., and McManus D.P. Prospects for a schistosome vaccine. Curr Drug Targets Immune Endocr Metab Disord 2 (2002) 281-290
4. Pearce E. Progress towards a vaccine for schistosomiasis. Acta Trop 86 (2003) 309-313
5. Bergquist R., Al-Sherbiny M., Barakat R., and Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop 82 (2002) 183-192
6. Kofta W., and Wedrychowicz H. c-DNA vaccination against parasitic infections: advantages and disadvantages. Vet Parasitol 100 1-2 (2001) 3-12
7. Dupré, Herv M., Schacht A.M., Capron A., and Riveau G. Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment. J Infect Dis 180 (1999) 454-463
8. Da'Dara A.A., Skelly P.J., Walker C.M., and Harn D.A. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunol 25 (2003) 429-437
9. Chlichlia K., Bahgat M., Ruppel A., and Schirrmacher V. DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine 20 (2001) 439-447
10. Shalaby K.A., Yin L., Thakur A., Christen L., Niles E.G., and LoVerde P.T. Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes. Vaccine 22 (2003) 130-136
11. Cook R.M., Carvalho-Queiroz C., Wilding G., and LoVerde P.T. Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun 72 (2004) 6112-6124
12. Fonseca C.T., Pacífico L.G., Barsante M.M., Rassi T., Cassali G.D., and Oliveira S.C. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone. Microbes Infect 8 (2006) 2509-2516
13. Nascimento E., Leão I.C., Pereira V.R., Gomes Y.M., Chikhlikar P., August T., et al. Protective immunity of single and multi-antigen DNA vaccines against schistosomiasis. Mem Inst Oswaldo Cruz 97 (2002) 105-109
14. Dietrich G., Gentschev I., Hess J., Ulmer J.B., Kaufmann S.H., and Goebel W. Delivery of DNA vaccines by attenuated intracellular bacteria. Immunol Today 20 (1999) 251-253
15. Weiss S., and Krusch S. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells. Biol Chem 382 (2001) 533-541
16. Pacheco L.G.C., Zucconi E., Mati V.L.T., Garcia R.M., Miyoshi A., Oliveira S.C., et al. Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis. Acta Trop 95 (2005) 132-142
17. Sambrook J., and Russell D.W. Molecular cloning: a laboratory manual (2001), NY Cold Spring Harbor Laboratory Press, Cold Spring Harbor
18. Pellegrino J., and Siqueira A.F. Técnica de perfusão para colheita de Schistosoma mansoni em cobaias experimentalmente infectadas. Ver Bras Malariol D Trop 8 (1956) 589-597
19. Donnelly J., Berry K., and Ulmer J.B. Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 33 (2003) 457-467
20. Andrade Z.A., and Warren K.S. Mild prolonged schistosomiasis: alterations in host response with time and the development of portal fibrosis. Trans R Soc Trop Méd Hyg 58 (1964) 447-456
21. Sandor M., Weinstock J.V., and Wynn T.A. Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol 24 (2003) 44-52
22. Wilson M.S., Mentink-Kane M.M., Pesce J.T., Ramalingam T.R., Thompson R., and Wynn T.A. Immunopathology of schistosomiasis. Immunol Cell Biol 85 (2007) 148-154
23. Pellegrino J., and Faria J. The oogram method for the screening of drugs in schistosomiasis mansoni. Am J Trop Med Hyg 14 (1965) 363-369
24. Pearce E.J., Caspar P., Grzych J.M., Lewis F.A., and Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 173 (1991) 159-166
25. Cheever A.W., Xu Y., Macedonia J.G., Cox T., Hieny S., and Sher A. The role of cytokines in the pathogenesis of hepatic granulomatous disease in Schistosoma mansoni infected mice. Mem Inst Oswaldo Cruz 87 (1992) 81-85
26. Hoffmann K.F., Cheever A.W., and Wynn T.A. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164 (2000) 6406-6416